Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2022-06-22 00:00:00 ET · period of report 2022-06-21 · accession 0001214659-22-008241 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-22 | 2022-06-21 | ALLO | Amado Rafael | CMO, EVP of R, D | S - Sale | $11.18 | -2,000 | 544.3K | -0.4% | -$22.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-21 | S | D | 2,000 | $11.18 | 544,257 | D | — | — |